192 related articles for article (PubMed ID: 37065996)
21. Mediastinal Hepatoid Adenocarcinoma Treated With Arterial Interventional Therapy: A Case Report and Review of Literature.
Zhang G; Wen C; Chen B; Dai H; Lin R; Huang Y; Xiang X
Front Oncol; 2022; 12():785888. PubMed ID: 35515120
[TBL] [Abstract][Full Text] [Related]
22. Assessing clinical pathological characteristics and gene expression patterns associated with hepatoid adenocarcinoma of the stomach.
Ge DF; Wang YK; Li YY; Liao XH; Zhu CY; Jiang B; Wang SN
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38758385
[TBL] [Abstract][Full Text] [Related]
23. Carcinosarcoma of the stomach with alpha-fetoprotein-producing hepatoid adenocarcinoma: an unexpected combination of two rare subtypes of gastric cancer in one tumor.
Li Z; Zhou Q; Lu J; Zhang H; Teng L
J Int Med Res; 2021 Aug; 49(8):3000605211037422. PubMed ID: 34407682
[TBL] [Abstract][Full Text] [Related]
24. Hepatoid adenocarcinoma of the lung with PD-L1 expression and the response to anti-PD-1 therapy: a case report.
Li Y; Liu L; Wang D; Tan X; Sui Y; Yang H
Front Oncol; 2023; 13():1257931. PubMed ID: 38074660
[TBL] [Abstract][Full Text] [Related]
25. Hepatoid adenocarcinoma of the lung without production of α-fetoprotein: A case report and review of the literature.
Sun JN; Zhang BL; Li LK; Yu HY; Wang B
Oncol Lett; 2016 Jul; 12(1):189-194. PubMed ID: 27347123
[TBL] [Abstract][Full Text] [Related]
26. Extremely high expression of serum alpha-fetoprotein level of gastric adenocarcinoma: a rare case with an unexpected well-prognosis.
Gong W; Shou D; Gong P
Springerplus; 2016; 5(1):2056. PubMed ID: 27995033
[TBL] [Abstract][Full Text] [Related]
27. Hepatoid adenocarcinoma of the stomach effectively treated with capecitabine with oxaliplatin as adjuvant chemotherapy: A case report and literature review.
Amioka J; Yanagawa S; Yamamoto Y; Nakahara M; Yonehara S; Noriyuki T
Int J Surg Case Rep; 2023 Nov; 112():108963. PubMed ID: 37856969
[TBL] [Abstract][Full Text] [Related]
28. Hepatoid adenocarcinoma of the stomach: a report of three cases.
Ye MF; Tao F; Liu F; Sun AJ
World J Gastroenterol; 2013 Jul; 19(27):4437-42. PubMed ID: 23885160
[TBL] [Abstract][Full Text] [Related]
29. Alpha-fetoprotein-producing hepatoid adenocarcinoma of the lung responsive to sorafenib after multiline treatment: A case report.
Xu SZ; Zhang XC; Jiang Q; Chen M; He MY; Shen P
World J Clin Cases; 2022 Oct; 10(28):10236-10243. PubMed ID: 36246828
[TBL] [Abstract][Full Text] [Related]
30. Alpha-Fetoprotein-Producing Extrahepatic Tumor: Clinical and Histopathological Significance of a Case.
Nuevo-Gonzalez JA; Cano-Ballesteros JC; Lopez B; Andueza-Lillo JA; Audibert L
J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S28-31. PubMed ID: 21826411
[TBL] [Abstract][Full Text] [Related]
31. [A case of liver metastasis of gastric hepatoid adenocarcinoma].
Jeong EH; Kim DH; Ma SH; Chung EJ; Bae SS; Park AY; Chu HJ
Korean J Hepatol; 2009 Jun; 15(2):201-8. PubMed ID: 19581772
[TBL] [Abstract][Full Text] [Related]
32. Solitary AFP- and PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis.
Iso Y; Sawada T; Shimoda M; Rokkaku K; Ohkura Y; Kubota K
Hepatogastroenterology; 2005; 52(66):1930-2. PubMed ID: 16334809
[TBL] [Abstract][Full Text] [Related]
33. Hepatoid adenocarcinoma of the stomach with metastatic choriocarcinoma of the liver: A case report of a rare subtype of gastric cancer with a complex treatment course.
Zhou Q; Zhou Y; Ouyang Y; Chen W; Zhou X
Front Surg; 2022; 9():968891. PubMed ID: 36157425
[TBL] [Abstract][Full Text] [Related]
34. SOX chemotherapy with anti-PD-1 and iNKT cell immunotherapies for stage IV gastric adenocarcinoma with liver metastases: A case report.
Li D; Liu M; Wang J; Guo J; Xu N; Lu J
Front Immunol; 2022; 13():1073094. PubMed ID: 36578494
[TBL] [Abstract][Full Text] [Related]
35. AFP-producing hepatoid adenocarcinoma of the stomach: a case report.
Vlachostergios PJ; Voutsadakis IA; Barbanis S; Karasavvidou F; Papandreou CN
Cases J; 2009 Dec; 2():9296. PubMed ID: 20062620
[TBL] [Abstract][Full Text] [Related]
36. Pathologic complete response to chemoimmunotherapy of an advanced gastric cancer patient with high PD-L1 expression, dMMR, and unique gut microbiota composition: A case report.
Jiang H; Wang J; Deng W
Front Oncol; 2023; 13():1150931. PubMed ID: 37007083
[TBL] [Abstract][Full Text] [Related]
37. A rare case of recurrent alpha-fetoprotein-producing gastric cancer without re-elevation of serum AFP.
Tomiyama K; Takahashi M; Fujii T; Kunisue H; Kanaya Y; Maruyama S; Yokoyama N; Shimizu N; Soda M
J Int Med Res; 2006; 34(1):109-14. PubMed ID: 16604831
[TBL] [Abstract][Full Text] [Related]
38. KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.
Liu C; Zheng S; Wang Z; Wang S; Wang X; Yang L; Xu H; Cao Z; Feng X; Xue Q; Wang Y; Sun N; He J
Cancer Commun (Lond); 2022 Sep; 42(9):828-847. PubMed ID: 35811500
[TBL] [Abstract][Full Text] [Related]
39. Hepatoid adenocarcinoma of the stomach: A case report and review of the literature.
Zhou RU; Cai Y; Yang YI; Xiang J; Chen Z
Oncol Lett; 2015 May; 9(5):2126-2128. PubMed ID: 26137025
[TBL] [Abstract][Full Text] [Related]
40. Early hepatoid adenocarcinoma of the stomach with signet ring cell carcinoma: A case report and clinicopathological features.
Wu X; Di L; Li C; Zhang S; Tan N; Huang J; Tuo B
Front Oncol; 2022; 12():1016447. PubMed ID: 36713511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
